These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33389957)

  • 1. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
    Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.
    Ling P; Yang D; Gu N; Xiao X; Lu J; Liu F; Zhou Z; Huang Q; Zhao J; Zhang M; Hu J; Luo S; Weng J; Yan J; Zheng X
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4309-e4317. PubMed ID: 34244734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
    Ohigashi M; Osugi K; Kusunoki Y; Washio K; Matsutani S; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Namba M; Koyama H
    J Diabetes Investig; 2021 Jun; 12(6):940-949. PubMed ID: 33058513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes.
    Bellido V; Aguilera E; Cardona-Hernandez R; Diaz-Soto G; González Pérez de Villar N; Picón-César MJ; Ampudia-Blasco FJ
    J Diabetes Sci Technol; 2023 Sep; 17(5):1326-1336. PubMed ID: 35470692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
    Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus.
    Kurozumi A; Okada Y; Mita T; Wakasugi S; Katakami N; Yoshii H; Kanda K; Nishida K; Mine S; Tanaka Y; Gosho M; Shimomura I; Watada H
    Diabetes Res Clin Pract; 2022 Apr; 186():109836. PubMed ID: 35314256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of different glycemic control metrics for optimizing management of diabetes.
    Kohnert KD; Heinke P; Vogt L; Salzsieder E
    World J Diabetes; 2015 Feb; 6(1):17-29. PubMed ID: 25685275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
    Kuroda N; Kusunoki Y; Osugi K; Ohigashi M; Azuma D; Ikeda H; Makino S; Otsuka A; Tamada D; Watanabe N; Washio K; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Koyama H;
    J Diabetes Investig; 2021 Feb; 12(2):244-253. PubMed ID: 32594655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.